BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 1.71 (-4.48%) May 24
At Loss
Market Cap:
€ 64.56M ($ 70.08M)
Enterprise V:
€ 90.31M ($ 98.03M)
Volume:
450.00
Avg Vol (2M):
2.63K
Also Trade In:

BioXcel Therapeutics Inc (FRA:BX2) Stock News, Headlines & Updates

BioXcel Therapeutics Inc Stock News from GuruFocus

Total 62
  • 1
  • 2
May 21, 2024
May 09, 2024
Apr 25, 2024
Apr 22, 2024
Apr 10, 2024
Mar 13, 2024
Mar 03, 2024
BioXcel Therapeutics Inc Commercial Day Transcript
GuruFocus Research • 11:55pm
BioXcel Therapeutics Inc Commercial Day Transcript
GuruFocus Research • 11:55pm
Total 62
  • 1
  • 2
Show
Entries

Headlines

Total 0
  • 1
No recent news